Skip to main content
OpenTrials
Completed

NCT Number: NCT04265625

Routine Use of FIBERoptic Bronchoscopic Guidance in Percutaneous TRACHeostomy

Tracheostomy is one of the most frequently performed techniques in intensive care units. For some authors endoscopic guide as part of the percutaneous tracheostomy (PT) might reduces the incidence of serious complications. However, for others, endoscopic guide increases the procedure cost, increases airway pressure and PaCO2 and sometimes requires the presence of another physician. International guidelines conclude that there is insufficient evidence to support the routine use of bronchoscopy during PT in order to decrease the number of complications. In addition the routine use of endoscopic guide is heterogeneous according the results of six published nation surveys. Extensive randomized trials to compare PT with endoscopic guide and without endoscopic guide are needed in order to clarify this controversial issue. This constitutes the justification of this trial.

Hypothesis: Percutaneous tracheotomy performed under endoscopic guide decreases the incidence of perioperative complications of the procedure.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hospital Universitario Infanta Leonor, Madrid, Spain

Loading trial locations.

About this study

Background

Tracheostomy is one of the most frequently performed techniques in intensive care units (ICU). A few years after the description of the percutaneous dilatational tracheostomy (PDT), endoscopic guide as part of the technique was performed in four patients. The authors concluded that the endoscopic guide provided advantages to the realization of PDT. Other authors have state that endoscopy, significantly reduces the incidence of serious complications such as posterior tracheal tears, false passage, pneumothorax and subcutaneous emphysema. However, currently endoscopic guide as part of the percutaneous tracheostomy is controversial. Although for some authors its use reduces the number of complications, others found that endoscopic guide increases the procedure cost, increases airway pressure and PaCO2 and sometimes requires the presence of another physician. Thus, some do not consider it necessary when the physicians have enough experience with percutaneous tracheostomy. International guidelines conclude that there is insufficient evidence to support the routine use of bronchoscopy during percutaneous tracheostomy in order to decrease the number of complications. In addition the routine use of endoscopic guide is heterogeneous according the published surveys. Specifically, in Spain its use was the lowest of the six published nation surveys. Extensive randomized trials to compare percutaneous tracheostomy with endoscopic guide and without endoscopic guide are needed in order to clarify this controversial issue. This constitutes the justification of this trial.

Hypothesis

Percutaneous tracheostomy performed under endoscopic control does not reduce the incidence of perioperative complications of the procedure in critically ill patients when it is performed by experienced physicians in patients without anatomical abnormalities.

Main goal

  • - To assess the incidence of perioperative complications of percutaneous tracheotomy under endoscopic guide versus blind percutaneous tracheotomy.
  • - To assess the ventilatory parameters during percutaneous tracheostomy with and without endoscopic control.

Methodology

Prospective, multicenter randomized study. Patients admitted to the ICU who need tracheostomy due to prolonged mechanical ventilation, who do not have neither contraindications to perform the percutaneous technique nor contraindications to perform fibrobronchoscopy will be randomized.

The percutaneous tracheostomy will be carried out with the single-step dilation method. For its realization, the usual protocol will be followed.

The included patients will be randomized 1:1 (percutaneous tracheostomy with endoscopic guide vs percutaneous tracheostomy without endoscopic guide). The randomization system will be by closed envelope. A sample size of 221 patients in each branch has been calculated.

The percutaneous tracheostomy and fiberoptic bronchoscopy will be performed by staff with experience with both procedures.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients over 18 years old requiring tracheotomy due to prolonged mechanical ventilation
  • That Family members or legal representatives have signed the information sheet and informed consent

Exclusion criteria

  • Patients with increased intracranial pressure according to intracranial pressure monitoring or suspected.
  • Patients who have any absolute or relative contraindication for the percutaneous tracheostomy realization
  • Patients with difficult airway

Treatment and study plan

endoscopic guidance

Device

Percutaneous tracheotomy performed by endoscopic guidance

Primary outcomes

  1. Number of patients with bleeding

    Time frame: From date of randomization until 24 hours later

    Bleeding with haemodynamic derangement or needing surgical review or transfusion of packed red cells.

  2. Number of patients with hypoxemia

    Time frame: From date of randomization until 24 hours later

    Hypoxemia: Oxygen arterial saturation (SaO2) < 85% during more than 90 seconds and/or arrhythmia or cardiac arrest related to hypoxemia.

  3. Number of patients in whom a loss of airway has ocurred

    Time frame: From randomization until the end of the procedure

    Loss of airway: Failure to be able to access the airway > 30 seconds.

  4. Number of patients with atelectasis

    Time frame: From date of randomization until 24 hours later

    Atelectasis: Total or partial lung collapse not present before the technique, evidenced at postoperative control.

  5. Number of patients with hypotension

    Time frame: From randomization until the end of the procedure

    Hypotension requiring treatment with vasopressors or >1000 ml of fluids during the procedure.

  6. Number of patients with barotrauma

    Time frame: From date of randomization until 24 hours later

    Barotrauma: Subcutaneous emphysema, mediastinal emphysema or pneumothorax related to the technique.

  7. Number of patients with posterior tracheal wall injury

    Time frame: From date of randomization until 24 hours later

    Posterior tracheal wall injury: Injury to membranous trachea by the needle, guide or dilator along with any related consequences (pneumomediastinum, pneumothorax, subcutaneous emphysema, tracheo-esophageal fistula)

  8. Number of patients in whom false passage has ocurred

    Time frame: From randomization until the end of the procedure

    False passage: Dilatation or insertion of the cannula out of the trachea lumen.

  9. Number of patients in whom cardiac arrest or death directly related to any complication arising from the technique occurred

    Time frame: From date of randomization until the ICU discharge

    Cardiac arrest or death

Secondary outcomes

  1. Peak airway pressure

    Time frame: From randomization until the end of the procedure

    Maximum peak airway pressure (cmH2O)

  2. Plateau pressure

    Time frame: From randomization until the end of the procedure

    Maximum plateau pressure (cmH2O)

  3. Tidal volume

    Time frame: From randomization until the end of the procedure

    Minimum tidal volume (mL)

  4. Arterial Blood Gas

    Time frame: From randomization until 15 minutes after the procedure

    Arterial blood gase at the beginning and the end of the procedure

  5. Oxygen saturation (SaO2)

    Time frame: From randomization until the end of the procedure

    Minimum arterial oxygen saturation (SaO2)

Other outcomes

  1. Mortality

    Time frame: From the date of randomization until the hospital discharge

    All-cause mortality at hospital discharge

Sponsors and collaborators

Lead sponsor

Instituto de Investigación Hospital Universitario La Paz

Other

Registry information

Official study title

The Role of Routine Fiberoptic Bronchoscopic Guidance During Percutaneous Tracheostomy. A Prospective Randomized Trial

Acronym: FIBERTRACH

Important dates

Study start
2019
Primary completion
2024
Study completion
2024
First posted
Feb 11, 2020
Registry last updated
Feb 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.